The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: CYTARABINE.     Injury: Acute lymphocytic leukaemia recurrent     Quarter: 2016Q3

Total Records: 11     Number of Pages: 1

Event ID DRUGNAME PT Drug Manufacturer Patient Age Sex Weight Date (YYYYMMDD) Country
124935692 CYTARABINE. Acute lymphocytic leukaemia recurrent PFIZER 33.00 YR F 0 20160708 US
125089722 CYTARABINE. Acute lymphocytic leukaemia recurrent AVENTIS 50.00 YR M 0 20160727 GB
125251951 CYTARABINE. Acute lymphocytic leukaemia recurrent BAXTER 33.00 YR F 0 20160704 US
125319753 CYTARABINE. Acute lymphocytic leukaemia recurrent AMGEN 50.00 YR M 0 20160808 GB
125351791 CYTARABINE. Acute lymphocytic leukaemia recurrent BAXTER 52.00 YR M 0 20160707 CA
125553242 CYTARABINE. Acute lymphocytic leukaemia recurrent TEVA 50.00 YR M 0 20160808 GB
125831182 CYTARABINE. Acute lymphocytic leukaemia recurrent AMGEN 2.00 YR M 12 KG 20160808 US
126317032 CYTARABINE. Acute lymphocytic leukaemia recurrent SANDOZ 33.00 YR M 0 20160809 US
126506601 CYTARABINE. Acute lymphocytic leukaemia recurrent 16.25 YR F 105 KG 20160812 US
127719821 CYTARABINE. Acute lymphocytic leukaemia recurrent BAXTER 8.77 YR F 0 20160922 US
127761161 CYTARABINE. Acute lymphocytic leukaemia recurrent BAXTER 56.00 YR F 0 20160923 US

Total Records: 11     Number of Pages: 1